Lucira Health, Inc. Common Stock
LHDX
LHDX was delisted on the 3rd of March, 2023.
28 hedge funds and large institutions have $24.2M invested in Lucira Health, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 15 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
26% less funds holding
Funds holding: 38 → 28 (-10)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
43% less capital invested
Capital invested by funds: $42.2M → $24.2M (-$17.9M)
67% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$1.41M |
| 2 |
Morgan Stanley
New York
|
+$449K |
| 3 |
ECG
EPIQ Capital Group
San Francisco,
California
|
+$222K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$84.3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.09K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$1.28M |
| 2 |
CWA
Choice Wealth Advisors
Waterville,
Maine
|
-$181K |
| 3 |
CM
CastleKnight Management
New York
|
-$124K |
| 4 |
Renaissance Technologies
New York
|
-$78K |
| 5 |
Millennium Management
New York
|
-$55K |
LHDX Hedge Fund Activity: Q3 2022 in Review
28 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Lucira Health, Inc. Common Stock (LHDX) for Q3 2022, worth a combined $24.2M — down 43% from $42.2M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of LHDX and 5 opened new positions — a net loss of 10 holders — while 6 trimmed existing stakes and 4 added.
The largest buyer was Citigroup, opening a new position worth an estimated $1.41M. The largest seller was Pura Vida Investments, exiting entirely with an estimated $1.28M sold.
- 28 institutional investors held Lucira Health, Inc. Common Stock (LHDX) as of Q3 2022, down from 38 in Q2 2022.
- Funds reported $24.2M of Lucira Health, Inc. Common Stock stock for Q3 2022, down 43% quarter-over-quarter.
- 5 funds opened new Lucira Health, Inc. Common Stock positions in Q3 2022 and 15 closed out, a net change of -10 holders.
- The largest Lucira Health, Inc. Common Stock buyer in Q3 2022 was Citigroup, an estimated $1.41M added.
- The largest Lucira Health, Inc. Common Stock seller in Q3 2022 was Pura Vida Investments, an estimated $1.28M sold.
Based on aggregated 13F filings for Q3 2022.